Full Length Research Paper
References
Altay A, Mehmet O, Duygu P (2011). Antibiotic susceptibilities and serotyping of clinical streptococcus agalactiae isolates. Balkan Med. J. 28:362-365. | ||||
Aziz RD, Hasan K, Nursei D (2011). Antibiotic susceptibilities of Group B Streptococcus. J. Exp. Clin. Med. 28:1-3. Crossref |
||||
Agence Nationale d'Accréditation et d'Evaluation en Santé (2001). Prévention anténatale du risque infectieux bactérien néonatal précoce. Recommandations pour la pratique clinique septembre (www.anaes.fr) | ||||
Bagnani A. Battisti E, Battisti A, Beneetti C, Burnelli I, Cavagna G, Cirillo A, Dani C, De Feo F, (1995). Prevalence of group B beta-hemolytic streptococcus colonisation in the sample of 23,312 pregnant women and newborn infants.Pediatr. Med. Chir. 17(4);295-7. | ||||
Balaka B, Dagnra A, Baeta S, Kessieand K, Assimadi K (2003).Portage génital bactérien au dernier trimestre de la grossesse et infectons néonatales précoces. Rapport CHU de lomé Togo.p 5-9. | ||||
Bernard Bonnin A.C. et Tetanye Ekoé (1985). Les méningites purulentes de l'enfant à Yaoundé : Aspects épidémiologiques et pronostiques. Ann.Soc.Belg. Méd. 65,59-68. | ||||
Bevilacqua G (1999).Prevenion of perinatal infectio caused by group B β-hemolyticstreptococcus.Acta Biomed AteneoParmense, 70(5-6):87-94. | ||||
Centers for Disease Control and Prevention. (2010) Prevention of Perinatal Group B Streptococcal Disease: Revised Guidelines from CDC. MMWR Recom. Rep. 59 (RP-10):1-23. | ||||
Claeys G, Verschraegen G, Temmerman M (2001). Modified Granada agar medium for the detection of group B streptococcus carriage in pregnant women. Clin. Microbiol. Infect. 7:22-34. Crossref |
||||
CNRS (2007) Streptococcus agalactiae GAPDH is a virulence-associated immunomodulatory protein. J. immunol. Paris, 1er février 2007. | ||||
Fari A (1998). Infections génitales: bactériologie et épidémiologie. In : Gynécologie. Paris : Aupelf/Uref Ellipses : 207-31. | ||||
Feriani A, Ben Abdallah H. Ben Saida N. Gozzi C. Boukadida J(2006). portage vaginal de Streptocoque agalactiae chez la femme enceinte en Tunisie. 99 (n°2):99-102. | ||||
Foumane P, Mboudou E, Dohbit JS, Nkemayim DC,Tchokoteu PF, Doh AS (2009). Streptocoques béta-hémolitique du groupe B et conséquences materno-fœtales observées à l'Hopital Général de Yaoundé : étude descriptive. Clin. Mother Child Health. 6(1):995-1001 | ||||
Horvath B, Grassely M, Lakatos F, Kneffel P (1998). Intrapatum administration of antibiotics in the prevention of neonatal streptococcus B infections. OrvHelitNov. 29:139(48):899-901 | ||||
Joelle Loulergue, Cecile Couche, Claude Gramick, PariceLaudat, Roland quentin (2003).Sensibilité aux antibiotiques des souches de streptocoque du groupe B de portage vaginal isolées en France. 69-70. | ||||
Kacou A, Faye-KetteAchi H, Sylla-koko FD, Akoua-Koffi C, Khonte AL, Acho YB, Bango KE, Dosso M (1988). Distribution des Streptocoques dans les produits biologiques analyses à Abidjan de 1982 a. | ||||
Kago I, Tetanye E, Doumbé P, N'koulou H, Wouafo NM (1990). les méningites purulentes néonatales à Yaoundé :Aspects épidémiologiques, cliniques et pronostiques. Med.Mal.infect . 20:507-511. Crossref |
||||
Lamagni TL, Neal S, Keshishian C, Alhaddad N, George R, Duckworth G, Vuopio-Varkila J, Efstratiou A. (2008). Severe Streptococcus pyogenes infections, United Kingdom. 2003–2004. Emerg. Inf. Dis. 14(2):202-209 Crossref |
||||
Maniatis AN, Palermos J, Kantzanou M, Maniatis NA, Christodoulou C, Legakis NJ (1996). Streptococcus agalactiae a vaginal pathogen. J. Med. Microbiol.Mar. 44(3):199-202. | ||||
Onipede A, Afefus O, Adeyemi A, Adejuyigbe E, Oyelese A, Ogunniyi T (2012). Group B Streptococcus carriage during late pregnancy in Ile-ife, Nigeria. Afr. J. Clin. Exper. Microbiol. 13(3):135-143. | ||||
Priscila AMN, Rôde B BS, Felipe PGN, Claudio FAP, Geraido RP, Priscila AM, Nakamura R, Beatriz BS, Felipe PG, Neves; Claudio FAP, Geraido R, Rosana RB (2011). Antimicrobial resistance profiles and genetic characterization of macrolide resistant isolates of Streptococcus agalactiae. Biolin. Int. 106 (2):119-122. | ||||
Quiroga M, Pegels E, Oviedo P, Pereyra E, Vergara M (2008). Antibiotic susceptibility patterns and prevalence of Group B Streptococcus isolated from pregnant women in Misiones, Argentina. Braz. J. Microbiol. p.39. | ||||
Rosa-Fraile M, Rodriguez-Granger J, Cueto-Lopez M (1999). Use of Granada medium to detect Group B streptococcal colonisation in pregnant women. J. Clin. Microbiol. 37:2674-2677. Pubmed |
||||
Seaward PG, Hannah ME, Myhr TL, Farine D, Ohlsson A, Wang EE (1998). "International multicenter term PROM study: evaluation of productors of neonatal infection in infant born to patients with premature rupture of membranes at term". Am. J Obstet Gynecol, 179(3 partie I):635-639. | ||||
Sahnoun O, Ben H, Noomen S, Ben AE, Mastouri M (2007) Sensibilité aux antibiotiques des souches de Streptococcus agalactiae à Monastir;Med.Mal,infect. 3(11):734-737. Crossref |
||||
Salah MA, Abouzeid MH (2009). Vaginal carriage and antibiotic susceptibility profile of Group B Streptococcus during late pregnancy in Ismailia, Egypt. J. Infect. Public Health 2:86-90. Crossref |
||||
Samar SB, Edet EU, Noura A (2012). Serotypes and antibiotic resistance in Group B Streptococcus isolated from patients at the Maternity Hospital, Kuwait. J. Med. Microbiol. 61:126-131. Crossref |
||||
Schrag S, Gorwitz R, Fultz-Butts K, Schuchat A (2002). Prevention of preinatal group Bstreptococcal disease. Revised guidelines from CDC. MMWR. 51:1-22. Pubmed |
||||
Schuchat A (2000).Epidemiology of group B streptococcal disease in the United States : shifting paradigms. J. Clin. Microbiol. 11(105):6-21. |
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0